Literature DB >> 8923594

Scleroderma epidemiology.

M D Mayes1.   

Abstract

The overall incidence and prevalence rates for scleroderma in the United States appear to be stable over the past 2 decades. Age-specific incidence rates are higher in black women than in white women, and diffuse disease is more common in the black population. Risk factors for disease development include female gender and may include HLA-DQ type. Diffuse disease, older age at onset, and early internal organ involvement are risk factors for reduced survival. Genetic factors appear to play a permissive role, whereas as yet undefined environmental factors play a more direct role in disease causation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8923594     DOI: 10.1016/s0889-857x(05)70299-4

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  10 in total

Review 1.  The genetics of systemic sclerosis.

Authors:  Randall W Johnson; Monty B Tew; Frank C Arnett
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

2.  Separate influences of birth order and gravidity/parity on the development of systemic sclerosis.

Authors:  Tonya Cockrill; Deborah J del Junco; Frank C Arnett; Shervin Assassi; Filemon K Tan; Terry McNearney; Michael Fischbach; Marilyn Perry; Maureen D Mayes
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-03       Impact factor: 4.794

Review 3.  The establishment and utility of a population-based registry to understand the epidemiology of systemic sclerosis.

Authors:  M D Mayes
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

Review 4.  [Scleroderma in childhood and adolescence. New aspects on classification, etiology and therapy].

Authors:  H J Girschick
Journal:  Z Rheumatol       Date:  2008-03       Impact factor: 1.372

5.  A case-control study of occupational exposures and systemic sclerosis.

Authors:  Massimo Bovenzi; Fabio Barbone; Federica E Pisa; Alberto Betta; Luciano Romeo; Alberta Tonello; Domenico Biasi; Paola Caramaschi
Journal:  Int Arch Occup Environ Health       Date:  2003-10-03       Impact factor: 3.015

6.  Oral health of Chinese people with systemic sclerosis.

Authors:  C H Chu; Clive M K Yeung; Ian A Lai; W Keung Leung; Mo Yin Mok
Journal:  Clin Oral Investig       Date:  2010-10-12       Impact factor: 3.573

7.  Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.

Authors:  Oliver Distler; Angela Del Rosso; Roberto Giacomelli; Paola Cipriani; Maria L Conforti; Serena Guiducci; Renate E Gay; Beat A Michel; Pius Brühlmann; Ulf Müller-Ladner; Steffen Gay; Marco Matucci-Cerinic
Journal:  Arthritis Res       Date:  2002-08-30

8.  Risk factors for the development of systemic sclerosis: a systematic review of the literature.

Authors:  Samuel Abbot; David Bossingham; Susanna Proudman; Caroline de Costa; Albert Ho-Huynh
Journal:  Rheumatol Adv Pract       Date:  2018-10-11

Review 9.  Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification.

Authors:  Changyi Yang; Shunli Tang; Dingxian Zhu; Yingguo Ding; Jianjun Qiao
Journal:  Front Med (Lausanne)       Date:  2020-11-19

10.  Endothelin-1 in systemic sclerosis.

Authors:  Mehrdad Aghaei; Farhad Gharibdost; Habib Zayeni; Maryam Akhlaghi; Sima Sedighi; Abduo Rahman Rostamian; Naser Aghdami; Mahdieh Shojaa
Journal:  Indian Dermatol Online J       Date:  2012-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.